Dexketoprofen is used to relieve moderate pain and reduce fever. It works similarly to ibuprofen by reducing inflammation and pain signals in the body.[1] Keterol is currently being investigated across 6 indications[3], with its most advanced program in Phase 3.[1]
Keterol is one of 166 small molecule programs targeting Rheumatic Disease. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
84 competitors in Cesarean Section
Keterol
Fentanyl-Morphine
Acetaminophen/ibuprofen
Ondansetron, Dexamethasone
Sebacoyl Dinalbuphine Ester
Morphine - .
Proamatine
Dynastat
Duragesic
Versed
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details